Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Thoughts on UBX?
-
Illumina Inc. (ILMN $134.87)
- $134.87 P/E (TTM): 31.08X Cap: $20.60B
- View ILMN Profile
- View Questions on ILMN
-
Pacific Biosciences of California Inc. (PACB $2.12)
- $2.12 Cap: $715M
- View PACB Profile
- View Questions on PACB
-
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
-
CRISPR Therapeutics AG (CRSP $56.68)
- $56.68 Cap: $5.40B
- View CRSP Profile
- View Questions on CRSP
-
Opko Health Inc. (OPK $1.38)
- $1.38 Cap: $1.05B
- View OPK Profile
- View Questions on OPK
-
Unity Biotechnology Inc. (UBX)
-
Intellia Therapeutics Inc. (NTLA $9.02)
- $9.02 Cap: $1.04B
- View NTLA Profile
- View Questions on NTLA
-
ARK Genomic Revolution ETF (ARKG $30.20)
- $30.20 P/E (TTM): 22.33X Cap: $1.27B
- View ARKG Profile
- View Questions on ARKG
Q: Hi guys. Would you be able to tell me your ratings on these medical stocks for growth and risk please. It would be a 3 year time frame minimum. Thks again for the great job you do.
Q: Thoughts on UBX:US?
Insiders
Share Information
SEC Filings
News and Media